Found: 54
Select item for more details and to access through your institution.
Refining the role of pegfilgrastim (a long-acting G-CSF) for prevention of chemotherapy-induced febrile neutropenia: consensus guidance recommendations.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Comparison of an extended-release formulation of granisetron (APF530) versus palonosetron for the prevention of chemotherapy-induced nausea and vomiting associated with moderately or highly emetogenic chemotherapy: results of a prospective, randomized, double-blind, noninferiority phase 3 trial.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Comparison of an extended-release formulation of granisetron (APF530) versus palonosetron for the prevention of chemotherapy-induced nausea and vomiting associated with moderately or highly emetogenic chemotherapy: results of a prospective, randomized, double-blind, noninferiority phase 3 trial
- Published in:
- Supportive Care in Cancer, 2015, v. 23, n. 3, p. 723, doi. 10.1007/s00520-014-2400-3
- By:
- Publication type:
- Article
Salmonella typhimurium Enteritis and Bacteremia in the Acquired Immunodeficiency Syndrome.
- Published in:
- Annals of Internal Medicine, 1985, v. 102, n. 2, p. 207, doi. 10.7326/0003-4819-102-2-207
- By:
- Publication type:
- Article
Multiple recurrences of acute tumor lysis syndrome in an indolent non-Hodgkin's lymphoma.
- Published in:
- 1985
- By:
- Publication type:
- journal article
Ruxolitinib and methylprednisolone for treatment of patients with relapsed/refractory multiple myeloma.
- Published in:
- British Journal of Haematology, 2023, v. 200, n. 6, p. 722, doi. 10.1111/bjh.18593
- By:
- Publication type:
- Article
Long‐term biological effects in sickle cell disease: insights from a post‐crizanlizumab study.
- Published in:
- British Journal of Haematology, 2021, v. 195, n. 4, p. e150, doi. 10.1111/bjh.17739
- By:
- Publication type:
- Article
Fostamatinib is an effective second‐line therapy in patients with immune thrombocytopenia.
- Published in:
- British Journal of Haematology, 2020, v. 190, n. 6, p. 933, doi. 10.1111/bjh.16959
- By:
- Publication type:
- Article
Bendamustine, bortezomib and rituximab produces durable complete remissions in patients with previously untreated, low grade lymphoma.
- Published in:
- British Journal of Haematology, 2018, v. 180, n. 3, p. 365, doi. 10.1111/bjh.15044
- By:
- Publication type:
- Article
Phase II study of bendamustine, bortezomib and dexamethasone ( BBD) in the first-line treatment of patients with multiple myeloma who are not candidates for high dose chemotherapy.
- Published in:
- British Journal of Haematology, 2017, v. 177, n. 2, p. 254, doi. 10.1111/bjh.14536
- By:
- Publication type:
- Article
Utilization of darbepoetin alfa and epoetin alfa for chemotherapy-induced anemia.
- Published in:
- American Journal of Health-System Pharmacy, 2005, v. 62, n. 1, p. 54
- By:
- Publication type:
- Article
Efficacy and safety of ferric carboxymaltose infusion in reducing anemia in patients receiving chemotherapy for nonmyeloid malignancies: A randomized, placebo‐controlled study (IRON‐CLAD).
- Published in:
- American Journal of Hematology, 2021, v. 96, n. 12, p. 1639, doi. 10.1002/ajh.26376
- By:
- Publication type:
- Article
A phase 1/2 study of oral panobinostat combined with melphalan for patients with relapsed or refractory multiple myeloma.
- Published in:
- Annals of Hematology, 2014, v. 93, n. 1, p. 89, doi. 10.1007/s00277-013-1910-2
- By:
- Publication type:
- Article
Randomized phase III trial of APF530 versus palonosetron in the prevention of chemotherapy-induced nausea and vomiting in a subset of patients with breast cancer receiving moderately or highly emetogenic chemotherapy.
- Published in:
- 2016
- By:
- Publication type:
- journal article
A Systematic Literature Review of Predictors of Erythropoiesis-Stimulating Agent Failure in Lower-Risk Myelodysplastic Syndromes.
- Published in:
- Journal of Clinical Medicine, 2024, v. 13, n. 9, p. 2702, doi. 10.3390/jcm13092702
- By:
- Publication type:
- Article
Avelumab, an anti-PD-L1 antibody, in patients with locally advanced or metastatic breast cancer: a phase 1b JAVELIN Solid Tumor study.
- Published in:
- Breast Cancer Research & Treatment, 2018, v. 167, n. 3, p. 671, doi. 10.1007/s10549-017-4537-5
- By:
- Publication type:
- Article
Efficacy and safety of darbepoetin alfa initiated at hemoglobin ≤10 g/dL in patients with stage IV cancer and chemotherapy-induced anemia.
- Published in:
- Cancer Medicine, 2016, v. 5, n. 12, p. 3445, doi. 10.1002/cam4.958
- By:
- Publication type:
- Article
Efficacy of oral palonosetron compared to intravenous palonosetron for the prevention of chemotherapy-induced nausea and vomiting associated with moderately emetogenic chemotherapy: a phase 3 trial.
- Published in:
- Supportive Care in Cancer, 2013, v. 21, n. 5, p. 1453, doi. 10.1007/s00520-012-1691-5
- By:
- Publication type:
- Article
Efficacy and tolerability of transdermal granisetron for the control of chemotherapy-induced nausea and vomiting associated with moderately and highly emetogenic multi-day chemotherapy: a randomized, double-blind, phase III study.
- Published in:
- 2011
- By:
- Publication type:
- journal article
Effect of Ferric Carboxymaltose Versus Low-Dose Intravenous Iron Therapy and Iron Sucrose on the Total Cost of Care in Patients with Iron Deficiency Anemia: A US Claims Database Analysis.
- Published in:
- Drugs - Real World Outcomes, 2024, v. 11, n. 2, p. 251, doi. 10.1007/s40801-024-00418-1
- By:
- Publication type:
- Article
Feasibility of Long-term Proteasome Inhibition in Multiple Myeloma by in-class Transition From Bortezomib to Ixazomib.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Long-term proteasome inhibition in newly diagnosed multiple myeloma (NDMM): US MM-6, a real-world study transitioning from bortezomib to ixazomib.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e11, doi. 10.1016/j.clml.2019.09.015
- By:
- Publication type:
- Article
Clinical and Disease Characteristics From REVEAL at Time of Enrollment (Baseline): Prospective Observational Study of Patients With Polycythemia Vera in the United States.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Patient-Reported Outcomes (PROs) From the Phase 3 A.R.R.O.W. Study Comparing Once-Weekly versus Twice-Weekly Carfilzomib Dosing in Relapsed and Refractory Multiple Myeloma (RRMM).
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2018, v. 18, p. S240, doi. 10.1016/j.clml.2018.07.130
- By:
- Publication type:
- Article
Patient-Reported Outcomes Data From REVEAL at the Time of Enrollment (Baseline): A Prospective Observational Study of Patients With Polycythemia Vera in the United States.
- Published in:
- 2018
- By:
- Publication type:
- journal article
A Multicenter, Open-Label, Phase 1b Study of Carfilzomib, Cyclophosphamide, and Dexamethasone in Newly Diagnosed Multiple Myeloma Patients (CHAMPION-2).
- Published in:
- 2017
- By:
- Publication type:
- journal article
A Multicenter, Open-Label, Phase 1b Study of Carfilzomib, Cyclophosphamide, and Dexamethasone in Newly Diagnosed Multiple Myeloma Patients (CHAMPION-2).
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. e14, doi. 10.1016/j.clml.2017.03.024
- By:
- Publication type:
- Article
A Phase II Trial of FOLFOX6 and Cetuximab in the First-line Treatment of Patients With Metastatic Colorectal Cancer.
- Published in:
- Clinical Colorectal Cancer, 2010, v. 9, n. 2, p. 102, doi. 10.3816/CCC.2010.n.014
- By:
- Publication type:
- Article
Chemotherapy-Induced Nausea and Vomiting: Identifying and Addressing Unmet Needs.
- Published in:
- Journal of Clinical Outcomes Management, 2013, v. 20, n. 8, p. 377
- By:
- Publication type:
- Article
Importance of Initial Complete Parenteral Iron Repletion on Hemoglobin Level Normalization and Health Care Resource Utilization: A Retrospective Analysis.
- Published in:
- Pharmacotherapy, 2019, v. 39, n. 10, p. 983, doi. 10.1002/phar.2319
- By:
- Publication type:
- Article
Safety and efficacy of parsaclisib in combination with obinutuzumab and bendamustine in patients with relapsed or refractory follicular lymphoma (CITADEL‐102): A phase 1 study.
- Published in:
- Hematological Oncology, 2023, v. 41, n. 5, p. 848, doi. 10.1002/hon.3209
- By:
- Publication type:
- Article
Efficacy and safety of IV ferumoxytol for adults with iron deficiency anemia previously unresponsive to or unable to tolerate oral iron.
- Published in:
- American Journal of Hematology, 2014, v. 89, n. 1, p. 7, doi. 10.1002/ajh.23582
- By:
- Publication type:
- Article
A multicenter phase II study of darinaparsin in relapsed or refractory Hodgkin's and non-Hodgkin's lymphoma.
- Published in:
- American Journal of Hematology, 2012, v. 87, n. 1, p. 111, doi. 10.1002/ajh.22232
- By:
- Publication type:
- Article
Confirming Diagnoses and Identifying Biomarkers Linked to Targeted Treatments with the bioT3 Approach.
- Published in:
- Personalized Medicine in Oncology, 2015, v. 4, n. 2, p. 74
- By:
- Publication type:
- Article
Relationship Between Initial Parenteral Iron Therapy Dosing and Treatment Effectiveness: A Real-World Retrospective Analysis.
- Published in:
- Journal of Blood Medicine, 2022, v. 13, p. 133, doi. 10.2147/JBM.S349070
- By:
- Publication type:
- Article
Can biosimilars help achieve the goals of US health care reform?
- Published in:
- Cancer Management & Research, 2017, v. 9, p. 197, doi. 10.2147/CMAR.S133442
- By:
- Publication type:
- Article
Pharmacokinetics, safety, and efficacy of APF530 (extended-release granisetron) in patients receiving moderately or highly emetogenic chemotherapy: results of two Phase II trials.
- Published in:
- Cancer Management & Research, 2015, v. 7, p. 83, doi. 10.2147/CMAR.S72626
- By:
- Publication type:
- Article
Use of transdermal and intravenous granisetron and the ability of the Hesketh score to assess nausea and vomiting induced by multiday chemotherapy.
- Published in:
- Cancer Management & Research, 2012, v. 4, p. 171, doi. 10.2147/CMAR.S31349
- By:
- Publication type:
- Article
Translating Research into Practice: the Prosigna® (PAM50) Gene Signature Assay.
- Published in:
- Clinical Advances in Hematology & Oncology, 2015, v. 13, p. 3
- By:
- Publication type:
- Article
A Phase I Trial Evaluating the Addition of Lenalidomide to Patients with Relapsed/Refractory Multiple Myeloma Progressing on Ruxolitinib and Methylprednisolone.
- Published in:
- Targeted Oncology, 2024, v. 19, n. 3, p. 343, doi. 10.1007/s11523-024-01049-w
- By:
- Publication type:
- Article
Phase 2, randomized, double-blind study of pracinostat in combination with azacitidine in patients with untreated, higher-risk myelodysplastic syndromes.
- Published in:
- 2017
- By:
- Publication type:
- journal article
A phase 2 randomized multicenter study of 2 extended dosing schedules of oral ezatiostat in low to intermediate-1 risk myelodysplastic syndrome.
- Published in:
- Cancer (0008543X), 2012, v. 118, n. 8, p. 2138, doi. 10.1002/cncr.26469
- By:
- Publication type:
- Article
Phase I/ II trial assessing bendamustine plus bortezomib combination therapy for the treatment of patients with relapsed or refractory multiple myeloma.
- Published in:
- British Journal of Haematology, 2013, v. 160, n. 3, p. 321, doi. 10.1111/bjh.12129
- By:
- Publication type:
- Article
Serum B-cell maturation antigen is elevated in multiple myeloma and correlates with disease status and survival.
- Published in:
- British Journal of Haematology, 2012, v. 158, n. 6, p. 727, doi. 10.1111/j.1365-2141.2012.09241.x
- By:
- Publication type:
- Article
A modified regimen of pegylated liposomal doxorubicin, bortezomib and dexamethasone (DVD) is effective and well tolerated for previously untreated multiple myeloma patients.
- Published in:
- British Journal of Haematology, 2011, v. 155, n. 5, p. 580, doi. 10.1111/j.1365-2141.2011.08884.x
- By:
- Publication type:
- Article
Monoclonal gammopathy of undetermined significance: a consensus statement.
- Published in:
- British Journal of Haematology, 2010, v. 150, n. 1, p. 28, doi. 10.1111/j.1365-2141.2010.08207.x
- By:
- Publication type:
- Article
Expanded safety experience with lenalidomide plus dexamethasone in relapsed or refractory multiple myeloma.
- Published in:
- British Journal of Haematology, 2009, v. 146, n. 2, p. 164, doi. 10.1111/j.1365-2141.2009.07728.x
- By:
- Publication type:
- Article
Efficacy and safety of melphalan, arsenic trioxide and ascorbic acid combination therapy in patients with relapsed or refractory multiple myeloma: a prospective, multicentre, phase II, single-arm study.
- Published in:
- British Journal of Haematology, 2006, v. 135, n. 2, p. 174, doi. 10.1111/j.1365-2141.2006.06280.x
- By:
- Publication type:
- Article
Chemotherapy-Induced Neutropenia and Febrile Neutropenia in the US: A Beast of Burden That Needs to Be Tamed?
- Published in:
- Oncologist, 2022, v. 27, n. 8, p. 625, doi. 10.1093/oncolo/oyac074
- By:
- Publication type:
- Article
A Phase II Study of FOLFOXIRI Plus Panitumumab Followed by Evaluation for Resection in Patients With Metastatic KRAS Wild-Type Colorectal Cancer With Liver Metastases Only.
- Published in:
- Oncologist, 2016, v. 21, n. 3, p. 279, doi. 10.1634/theoncologist.2015-0439
- By:
- Publication type:
- Article